PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17635080-6	2007	IGF-II levels were significantly higher in the SZ group (p=0.02) and correlated positively with levels of atherogenic lipoproteins--total cholesterol, low-density lipoprotein, apoB--and IGFBP-3.	Cholesterol	138-149	insulin like growth factor 2	Homo sapiens	0-6	
8636318-3	1996	IGF-I was not significantly associated with cardiovascular risk factors but IGF-II levels correlated positively with total and LDL cholesterol most markedly in the diet treated group (0.72, p < 0.01 and 0.76, p < 0.01 respectively).	Cholesterol	131-142	insulin like growth factor 2	Homo sapiens	76-82	
9549041-7	1997	Northern blot analysis further demonstrated that GH amplification of IGF-II-induced steroidogenesis can be attributed, at least partially, to enhanced IGF-II-induced cytochrome P450 cholesterol side-chain cleavage mRNA by GH.	Cholesterol	182-193	insulin like growth factor 2	Homo sapiens	69-75	
9549041-7	1997	Northern blot analysis further demonstrated that GH amplification of IGF-II-induced steroidogenesis can be attributed, at least partially, to enhanced IGF-II-induced cytochrome P450 cholesterol side-chain cleavage mRNA by GH.	Cholesterol	182-193	insulin like growth factor 2	Homo sapiens	151-157	
29724293-5	2018	Simple linear regression analysis showed that systolic blood pressure (SBP), mean arterial pressure (MAP), and levels of serum low-density lipoprotein (LDL) and cholesterol (CHOL) were related to plasma preptin levels.	Cholesterol	161-172	insulin like growth factor 2	Homo sapiens	203-210	
31182144-12	2019	CONCLUSION: Increased methylation level in the IGF2 gene was associated with early-life exposure to severe famine, and this change was also positively associated with total cholesterol in late adulthood.	Cholesterol	173-184	insulin like growth factor 2	Homo sapiens	47-51	
8396578-11	1993	IGF-II increased the abundance of ACTH-stimulated mRNAs encoding cholesterol side-chain cleavage cytochrome P450 (P450scc), 17 alpha hydroxylase/17,20 lyase P450 (P450c17), and 3 beta-hydroxysteroid dehydrogenase (3 beta HSD).	Cholesterol	65-76	insulin like growth factor 2	Homo sapiens	0-6	
3349907-3	1988	Fetal testicular IGF-II mRNA decreases significantly with increasing gestational age, in parallel with our previous measurements of the mRNAs for the steroidogenic enzymes P450scc (cholesterol side-chain cleavage enzyme) and P450c17 (17 alpha-hydroxylase/17,20 lyase) (J. Clin.	Cholesterol	181-192	insulin like growth factor 2	Homo sapiens	17-23	
3031644-8	1987	Accumulation of mRNA for the cholesterol side-chain-cleavage monooxygenase [P450scc [corrected]; cholesterol, reduced-adrenal-ferredoxin:oxygen oxidoreductase (side-chain-cleaving), EC 1.14.15.6] was regulated in parallel with IGF-II mRNA in all these steroidogenic tissues.	Cholesterol	29-40	insulin like growth factor 2	Homo sapiens	227-233	
29724293-5	2018	Simple linear regression analysis showed that systolic blood pressure (SBP), mean arterial pressure (MAP), and levels of serum low-density lipoprotein (LDL) and cholesterol (CHOL) were related to plasma preptin levels.	Cholesterol	174-178	insulin like growth factor 2	Homo sapiens	203-210	
27489546-0	2016	Corrigendum: Transient Hepatic Overexpression of Insulin-Like Growth Factor 2 Induces Free Cholesterol and Lipid Droplet Formation.	Cholesterol	91-102	insulin like growth factor 2	Homo sapiens	49-77	
24081183-0	2014	Insulin-like growth factor-II and insulin-like growth factor binding protein-2 prospectively predict longitudinal elevation of HDL-cholesterol in type 2 diabetes.	Cholesterol	131-142	insulin like growth factor 2	Homo sapiens	0-29	
24081183-7	2014	HDL cholesterol at baseline was associated with log-IGF-II concentration in a model adjusted for age, gender, baseline body-mass index (BMI), estimated glomerular filtration rate (eGFR) and lipid-lowering therapy.	Cholesterol	4-15	insulin like growth factor 2	Homo sapiens	52-58	
24081183-9	2014	A higher circulating IGF-II concentration at baseline was also associated with longitudinal increase in HDL-cholesterol in mixed-effects regression analyses independent of IGF-I, IGFBP-1, IGFBP-2, IGFBP-3, age, gender, eGFR, BMI and lipid-lowering therapy.	Cholesterol	108-119	insulin like growth factor 2	Homo sapiens	21-27	
24081183-12	2014	CONCLUSION: Our analyses based on "real world" data demonstrate that higher baseline IGF-II and IGFBP-2 predict increased HDL concentration over time, implicating IGF-II in modulation of circulating HDL-cholesterol concentrations.	Cholesterol	203-214	insulin like growth factor 2	Homo sapiens	163-169